Literature DB >> 11069791

Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy.

A Matteelli1, C Casalini, M C Raviglione, I El-Hamad, C Scolari, E Bombana, M Bugiani, M Caputo, C Scarcella, G Carosi.   

Abstract

In a multicenter, prospective, randomized, open-label study of isoniazid-preventive therapy (IPT) for latent tuberculosis infection, illegal immigrants from countries where tuberculosis is highly endemic were enrolled at two clinical sites in Northern Italy. Of 208 eligible subjects, 82 received supervised IPT at a dose of 900 mg twice weekly for 6 mo (Regimen A), 73 received unsupervised IPT 900 mg twice weekly for 6 mo (Regimen B), and 53 received unsupervised IPT 300 mg daily for 6 mo (Regimen C). Supervised IPT was delivered at either one tuberculosis clinic or one migrant clinic. The probability of completing a 26-wk regimen was 7, 26, and 41% in Regimens A, B, and C, respectively (p < 0.005, Log- rank test calculated using Kaplan-Meier plots). The mean time to dropout was 3. 8, 6, and 6.2 wk in Regimens A, B, and C, respectively (p = 0.003 for regimen A versus either Regimens B or C). Treatment was stopped in five subjects (2.4%) because of adverse events. The rate of completion of preventive therapy for latent tuberculosis infection among illegal immigrants was low. Supervised, clinic-based administration of IPT significantly reduced adherence. Alternative strategies to implement preventive therapy in illegal immigrants are clearly required.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069791     DOI: 10.1164/ajrccm.162.5.9912062

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

1.  Impact of immigration and HIV infection on tuberculosis incidence in an area of low tuberculosis prevalence.

Authors:  I Baussano; M Bugiani; D Gregori; C Pasqualini; V Demicheli; F Merletti
Journal:  Epidemiol Infect       Date:  2006-04-20       Impact factor: 2.451

2.  Risk of tuberculin conversion among healthcare workers and the adoption of preventive measures.

Authors:  Iacopo Baussano; Massimiliano Bugiani; Aurelia Carosso; Dario Mairano; Anna Pia Barocelli; Marina Tagna; Vincenza Cascio; Pavilio Piccioni; Walter Arossa
Journal:  Occup Environ Med       Date:  2006-08-15       Impact factor: 4.402

3.  Stigma and Therapy Completion for Latent Tuberculosis among Haitian-origin Patients.

Authors:  Jeannine Coreil; Michael Lauzardo; Heather Clayton
Journal:  Fla Public Health Rev       Date:  2010-04-08

Review 4.  A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries.

Authors:  Lorenzo Zammarchi; Gianluigi Casadei; Marianne Strohmeyer; Filippo Bartalesi; Carola Liendo; Alberto Matteelli; Maurizio Bonati; Eduardo Gotuzzo; Alessandro Bartoloni
Journal:  BMC Health Serv Res       Date:  2015-09-24       Impact factor: 2.655

Review 5.  Health and access to care for undocumented migrants living in the European Union: a scoping review.

Authors:  Aniek Woodward; Natasha Howard; Ivan Wolffers
Journal:  Health Policy Plan       Date:  2013-08-16       Impact factor: 3.344

6.  Treatment completion among TB patients returned to the community from a large urban jail.

Authors:  Seijeoung Kim; Kathleen Crittenden
Journal:  J Community Health       Date:  2007-04

7.  Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive exploratory study.

Authors:  Patrick Bodenmann; Paul Vaucher; Hans Wolff; Bernard Favrat; Fanny de Tribolet; Eric Masserey; Jean-Pierre Zellweger
Journal:  BMC Infect Dis       Date:  2009-03-24       Impact factor: 3.090

8.  Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patients.

Authors:  Katie Butcher; Beverley-Ann Biggs; Karin Leder; Chris Lemoh; Daniel O'Brien; Caroline Marshall
Journal:  BMC Res Notes       Date:  2013-08-29

Review 9.  Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review.

Authors:  Anke L Stuurman; Marije Vonk Noordegraaf-Schouten; Femke van Kessel; Anouk M Oordt-Speets; Andreas Sandgren; Marieke J van der Werf
Journal:  BMC Infect Dis       Date:  2016-06-08       Impact factor: 3.090

10.  Initiation and completion rates for latent tuberculosis infection treatment: a systematic review.

Authors:  Andreas Sandgren; Marije Vonk Noordegraaf-Schouten; Femke van Kessel; Anke Stuurman; Anouk Oordt-Speets; Marieke J van der Werf
Journal:  BMC Infect Dis       Date:  2016-05-17       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.